“…However, it is important to note that although treatment-mediated changes in PDRP expression correlate significantly with improvement in UPDRS ratings, the metabolic and clinical disease descriptors are not interchangeable. Indeed, intersubject differences in these measures generally have less than 50% of their variability in common, as observed in correlations between PDRP scores and motor UPDRS ratings obtained at baseline or during therapy (e.g., Feigin et al, 2002;Lozza et al, 2004;Trošt et al, 2006). Thus, it is likely that the objective imaging-based network measure may provide unique information about disease severity or the Test-retest reliability of Parkinson's disease-related brain network Y Ma et al treatment response that is not captured by the simpler and more accessible clinical rating scales.…”